Quantcast
TG Therapeutics Inc (NASDAQ: TGTX) | The Mesh Report

TG Therapeutics Inc (NASDAQ: TGTX)

the Mesh Report Staff August 3, 2017 Comments Off on TG Therapeutics Inc (NASDAQ: TGTX)

TG Therapeutics, Inc., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases primarily in the United States.

Take a look at the 1-year chart of Fastenal (NASDAQ: TGTX) with the added notations:

1-year chart of Fastenal (NASDAQ: TGTX)

TGTX has bounced on top of its $10 support (green) multiple times during the past five months. Now that the stock appears to have started to roll back down towards that support again, traders should be able to expect some sort of bounce. However, if the $10 support level breaks, lower prices should follow.

ATTENTION SUBSCRIBERS!

Join our new Linkedin Group by clicking the link below:

Stock Trading & Investing for Everyone

The Tale of the Tape: TGTX has a key area of support at $10. A trader could enter a long position at $10 with a stop placed under the level. If the stock were to break below the support, a short position could be entered instead.

Before making any trading decision, decide which side of the trade you believe gives you the highest probability of success. Do you prefer the short side of the market, long side, or do you want to be in the market at all? If you haven’t thought about it, review the overall indices themselves. For example, take a look at the S&P 500. Is it trending higher or lower? Has it recently broken through a key resistance or support level? Making these decisions ahead of time will help you decide which side of the trade you believe gives you the best opportunities.

No matter what your strategy or when you decide to enter, always remember to use protective stops and you’ll be around for the next trade. Capital preservation is always key!

Good luck!

Christian Tharp, CMT

Follow me on Twitter: @cmtstockcoach



Comments are closed.